| Primary |
| Mucopolysaccharidosis Ii |
58.2% |
| Product Used For Unknown Indication |
23.1% |
| Premedication |
9.5% |
| Epilepsy |
1.2% |
| Mucopolysaccharidosis |
0.9% |
| Headache |
0.8% |
| Asthma |
0.7% |
| Supplementation Therapy |
0.7% |
| Convulsion |
0.6% |
| Infusion Related Reaction |
0.6% |
| Pain |
0.5% |
| Sleep Disorder |
0.5% |
| Hypertension |
0.4% |
| Wheezing |
0.4% |
| Cardiovascular Disorder |
0.3% |
| Hypersensitivity |
0.3% |
| Lung Disorder |
0.3% |
| Nasopharyngitis |
0.3% |
| Prophylaxis |
0.3% |
| Agitation |
0.2% |
|
| Urticaria |
15.8% |
| Infusion Related Reaction |
13.4% |
| Death |
13.0% |
| Pneumonia |
8.6% |
| Respiratory Failure |
7.9% |
| Convulsion |
7.5% |
| Pyrexia |
5.8% |
| Respiratory Disorder |
3.8% |
| Wheezing |
3.1% |
| Tachycardia |
2.7% |
| Dyspnoea |
2.4% |
| Respiratory Arrest |
2.4% |
| Cardio-respiratory Arrest |
2.1% |
| Tachypnoea |
2.1% |
| Respiratory Tract Infection |
1.7% |
| Tremor |
1.7% |
| Upper Respiratory Tract Infection |
1.7% |
| Vomiting |
1.7% |
| Hospitalisation |
1.4% |
| Oxygen Saturation Decreased |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
58.6% |
| Mucopolysaccharidosis Ii |
28.6% |
| Premedication |
3.9% |
| Hypovitaminosis |
2.5% |
| Epilepsy |
1.5% |
| Prophylaxis |
1.5% |
| Convulsion |
1.0% |
| Chills |
0.5% |
| Eye Disorder |
0.5% |
| Pyrexia |
0.5% |
| Respiratory Rate Increased |
0.5% |
| Sleep Disorder |
0.5% |
|
| Urticaria |
22.2% |
| Infusion Related Reaction |
13.0% |
| Headache |
11.1% |
| Paraesthesia |
7.4% |
| Overdose |
5.6% |
| Scoliosis |
5.6% |
| Tricuspid Valve Incompetence |
5.6% |
| Convulsion |
3.7% |
| Drug Effect Decreased |
3.7% |
| Osteomyelitis |
3.7% |
| Cardiac Arrest |
1.9% |
| Cyanosis |
1.9% |
| Death |
1.9% |
| Malnutrition |
1.9% |
| Migraine |
1.9% |
| Nausea |
1.9% |
| Pyrexia |
1.9% |
| Respiratory Failure |
1.9% |
| Respiratory Rate Increased |
1.9% |
| Sinus Congestion |
1.9% |
|
| Concomitant |
| Mucopolysaccharidosis Ii |
50.0% |
| Abnormal Behaviour |
25.0% |
| Body Height Below Normal |
25.0% |
|
| Device Dislocation |
50.0% |
| Sensory Disturbance |
50.0% |
|
